Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results | 124 | ACCESSWIRE | LOS GATOS, CA / ACCESSWIRE / April 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint)... ► Artikel lesen | |
01.04. | Tenon Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
29.03. | Tenon Medical, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
28.03. | Tenon Medical, Inc.: Tenon Medical Appoints Kristine Jacques to its Board of Directors | 494 | ACCESSWIRE | Experienced Medical Devices Industry Executive Joins Tenon's Board of DirectorsLOS GATOS, CA / ACCESSWIRE / March 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming... ► Artikel lesen | |
26.03. | Tenon Medical, Inc.: Tenon Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran SI Joint Fusion System | 214 | ACCESSWIRE | Preliminary SI Joint Fusion Results Based on Independent Radiologist Review Indicate Robust Fusion at 12-Months Post-ProcedureInitial Patient Results Demonstrate Marked Improvements in Pain Scores and... ► Artikel lesen | |
14.03. | Tenon Medical, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
13.03. | Tenon Medical, Inc. (TNON) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
12.03. | Tenon Medical Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
12.03. | Tenon Medical GAAP EPS of -$8.59 beats by $1.13, revenue of $2.93M misses by $0.25M | 2 | Seeking Alpha | ||
12.03. | Recap: Tenon Medical Q4 Earnings | 3 | Benzinga.com | ||
12.03. | Tenon Medical, Inc.: Tenon Medical Reports Fourth Quarter and Full Year 2023 Financial Results | 296 | ACCESSWIRE | Fourth Quarter 2023 Revenue Increased 192% Year-Over-YearFull Year 2023 Revenue Increased 324% Year-Over-YearSurgical Procedures Increased 179% Year-Over-Year in the Fourth Quarter and 312% for the... ► Artikel lesen | |
27.02. | Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results | 207 | ACCESSWIRE | LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint)... ► Artikel lesen | |
22.02. | Tenon Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
22.02. | Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant | 216 | ACCESSWIRE | Received Notice of Allowance from the USPTO on February 15, 2024LOS GATOS, CA / ACCESSWIRE / February 22, 2024 / Tenon Medical, Inc. ("Tenon" or the "Company") (NASDAQ:TNON), a company transforming... ► Artikel lesen | |
21.02. | Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred Stock | 620 | ACCESSWIRE | Raises Approximately $2.6 Million in Gross ProceedsRetires $1.25 Million in Secured DebtLOS GATOS, CA / ACCESSWIRE / February 21, 2024 / Tenon Medical, Inc. ("Tenon" or the "Company") (NASDAQ:TNON)... ► Artikel lesen | |
14.02. | DTSS, TNON and BREA among mid-day movers | 5 | Seeking Alpha | ||
11.01. | Tenon Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
08.01. | Tenon Medical, Inc. Announces Second Adjournment of Special Meeting of Stockholders | 409 | ACCESSWIRE | Meeting adjourned to Tuesday, January 30, 2024, at 1:30pm Pacific TimeLOS GATOS, CA / ACCESSWIRE / January 8, 2024 / Tenon Medical, Inc. ("Tenon" or the "Company") (NASDAQ:TNON), a company transforming... ► Artikel lesen | |
26.12.23 | Tenon Medical, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
20.12.23 | Tenon Medical, Inc.: Tenon Medical Announces Participation in Two Key Immersive Webinar Physician Training Programs Featuring the Company's Catamaran SI Joint Fusion System | 505 | ACCESSWIRE | ~ Training Programs Led by Dr. Matthew Davies from Duluth, MN and Included Simulated Catamaran Procedure ~~ Reached Approximately 60 Health Care Providers Between the Two Catamaran Training Sessions... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 75,98 | +0,12 % | Medtronic Plc-Aktie läuft heute schlechter (75,3286 €) | Der Anteilsschein von Medtronic Plc notiert am Dienstag etwas leichter. Das Wertpapier kostete zuletzt 80,46 US-Dollar. Heute hat sich an der US-amerikanischen Börse der Anteilsschein von Medtronic... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,066 | -5,44 % | Nugen Medical Devices Inc: Nugen Medical two million shares for debt | ||
TEMPEST THERAPEUTICS | 3,480 | +1,64 % | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
TENET | 112,00 | 0,00 % | Tenet Healthcare Raises 2024 Financial Outlook | WASHINGTON (dpa-AFX) - Tenet Healthcare (THC) said its fiscal 2024 adjusted EBITDA is now expected to be in the range of $3.5 billion to $3.7 billion, a $215 million increase. Adjusted earnings... ► Artikel lesen | |
BIOCEPT | 6,800 | 0,00 % | NSE - BIOCEPT INC - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
TEMPUR SEALY | 48,600 | +3,40 % | Critical Insights From Tempur Sealy Intl Analyst Ratings: What You Need To Know | ||
INTELLIGENT BIO SOLUTIONS | 3,870 | 0,00 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
VIVOS THERAPEUTICS | 2,590 | -0,38 % | Vivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement | LITTLETON, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and technology company specializing in the development... ► Artikel lesen | |
LUMIRADX | 0,016 | -1,25 % | Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival ... | NEW YORK" March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.'s securities were suspended on August... ► Artikel lesen | |
INVO BIOSCIENCE | 0,925 | -0,66 % | INVO Bioscience, Inc. - 10-K/A, Annual Report | ||
SIEMENS HEALTHINEERS | 51,90 | +1,37 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
FRESENIUS | 27,950 | -0,07 % | Fresenius mit Verkauf: Wachstum des Kerngeschäfts im Fokus - Aktie zieht weiter an | Fresenius kommt bei seiner Neuausrichtung weiter voran. Wie der Gesundheitskonzern am Donnerstagabend mitgeteilt hat, soll das Vamed-Reha-Geschäft veräußert werden. Fresenius werde aber ein Drittel... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 39,260 | -2,34 % | Kursgewinne für die Aktie von Fresenius Medical Care (38,13 €) | Im deutschen Wertpapierhandel liegt der Anteilsschein von Fresenius Medical Care aktuell im Plus. Das Wertpapier kostete zuletzt 38,13 Euro. Freuen können sich gegenwärtig die Aktionäre von Fresenius... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 64,31 | +4,16 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
CARL ZEISS MEDITEC | 97,80 | +0,46 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen |